Evidence map›Paper›PMID 26390865›Full record

ArticleBMC bioinformatics2015

Boosting for high-dimensional two-class prediction.

Rok Blagus, Lara Lusa

Abstract read
In one paragraph

Article in BMC bioinformatics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. A multidimensional analysis of the 21Scientific reports · 2025
    Article
  2. Article
  3. Article
  4. Advanced machine learning schemes for prediction COJournal of advanced research · 2025
    Article
  5. Article
  6. VirVACPRED: A Web Server for Prediction of Protective Viral Antigens.International journal of peptide research and therapeutics · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rok BlagusInstitute for Biostatistics and Medical Informatics, University of Ljubljana, Vrazov trg 2, Ljubljana, Slovenia. rok.blagus@mf.uni-lj.si.
Lara LusaInstitute for Biostatistics and Medical Informatics, University of Ljubljana, Vrazov trg 2, Ljubljana, Slovenia. lara.lusa@mf.uni-lj.si.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn clinical research prediction models are used to accurately predict the outcome of the patients based on some of their characteristics. For high-dimensional prediction models (the number of variables greatly exceeds the number of samples) the choice of an appropriate classifier is crucial as it was observed that no single classification algorithm performs optimally for all types of data. Boosting was proposed as a method that combines the classification results obtained using base classifiers, where the sample weights are sequentially adjusted based on the performance in previous iterations. Generally boosting outperforms any individual classifier, but studies with high-dimensional data showed that the most standard boosting algorithm, AdaBoost.M1, cannot significantly improve the performance of its base classier. Recently other boosting algorithms were proposed (Gradient boosting, Stochastic Gradient boosting, LogitBoost); they were shown to perform better than AdaBoost.M1 but their performance was not evaluated for high-dimensional data.

resultsIn this paper we use simulation studies and real gene-expression data sets to evaluate the performance of boosting algorithms when data are high-dimensional. Our results confirm that AdaBoost.M1 can perform poorly in this setting, often failing to improve the performance of its base classifier. We provide the explanation for this and propose a modification, AdaBoost.M1.ICV, which uses cross-validated estimates of the prediction errors and outperforms the original algorithm when data are high-dimensional. The use of AdaBoost.M1.ICV is advisable when the base classifier overfits the training data: the number of variables is large, the number of samples is small, and/or the difference between the classes is large. To a lesser extent also Gradient boosting suffers from similar problems. Contrary to the findings for the low-dimensional data, shrinkage does not improve the performance of Gradient boosting when data are high-dimensional, however it is beneficial for Stochastic Gradient boosting, which outperformed the other boosting algorithms in our analyses. LogitBoost suffers from overfitting and generally performs poorly.

conclusionsThe results show that boosting can substantially improve the performance of its base classifier also when data are high-dimensional. However, not all boosting algorithms perform equally well. LogitBoost, AdaBoost.M1 and Gradient boosting seem less useful for this type of data. Overall, Stochastic Gradient boosting with shrinkage and AdaBoost.M1.ICV seem to be the preferable choices for high-dimensional class-prediction.

Indexed as

AlgorithmsComputer SimulationDatabases, FactualGene Expression ProfilingHumansNeoplasmsOligonucleotide Array Sequence Analysis

Identifiers

PMID26390865
PMCPMC4578758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.